NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

European shares slip after China reforms underwhelm; tech leads losses

Published 05/03/2024, 08:16
Updated 05/03/2024, 17:51
© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, March 1, 2024. REUTERS/Staff/File Photo
TCFP
-
STOXX
-

By Khushi Singh and Ankika Biswas

(Reuters) -Europe's main index dipped on Tuesday, as mining shares weakened with metal prices on a lack of substantial stimulus from top consumer China, while investors awaited this week's euro zone and U.S. economic data and an ECB policy decision.

The pan-European STOXX 600 index shed 0.3%, a day after hitting an all-time high, with technology losing 1.6%, tracking weakness in its U.S. peers.

A European Central Bank interest rate decision is scheduled for Thursday, while euro zone retail sales and gross domestic product reports and a slew of U.S. jobs data are due this week.

"The only thing that would improve the situation from here is either economic growth picking up, a tailwind for stocks, and if the ECB's cutting rates," said Michael Field, European market strategist at Morningstar.

"What the ECB doesn't want to do is back themselves into a corner whereby they promise to cut rates in June, and then you see a backlash in markets."

China's ambitious 2024 economic growth target of around 5% missed some investors' expectations for stimulus measures.

The basic resources sector dropped 0.9% to a four-month low.

China-exposed luxury giants including Hermes and LVMH (EPA:LVMH) each lost over 1%, with the broader sector slipping to a near two-week low.

Utilities jumped 1.8% as the battered rate-sensitive sector benefited from a drop in bond yields.

Among headlining stocks, Novo Nordisk (CSE:NOVOb) dropped 2.5% after hitting a record high in early trade. A study showed its widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, cutting risk of major cardiac events and death by 24%.

Dialysis firm Fresenius Medical gained 11.5%, along with its U.S. peers, after the kidney trial data disappointed some investors.

British equipment rental firm Ashtead (LON:AHT) slumped 9.4% following a weak rental revenue growth outlook, while Swedish car manufacturer Volvo Car shed 7.6% after lower-than-expected February sales.

Bayer (ETR:BAYGN) lost 7.6%. The company will hold off on plans to break apart the group for up to three years, leaving investors dubious about whether enough is being done to revive its fortunes.

Norwegian recycling machinery maker Tomra Systems jumped 12.2%, with local analysts citing the European Union's sustainable packaging deal to cut packaging waste.

© Reuters. FILE PHOTO: The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, March 1, 2024. REUTERS/Staff/File Photo

France's Thales climbed 9.1% after unveiling higher-than-expected 2023 sales, cash and profits.

Investors also monitored data showing signs of recovery in euro zone business activity last month, while producer prices in January fell much more than expected month-on-month.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.